Can cinacalcet replace parathyroid intervention in severe secondary hyperparathyroidism?

Therapeutic Apheresis and Dialysis

Volumn 13, Issue SUPPL. 1, 2009, Pages

  Kakuta, Takatoshi ^a   Tanaka, Reika ^a   Kanai, Genta ^a   Sawaya, Asako ^a   Hirukawa, Takashi ^a   Sato, Atsuhiro ^a   Saito, Akira ^a  

^a TOKAI UNIVERSITY   (Japan)

Author keywords

Chronic kidney disease; Cinacalcet; JSDT guidelines; Parathyroid intervention; PTH; Secondary hyperparathyroidism

Indexed keywords

CALCIUM; CINACALCET; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROID HYPERPLASIA; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; TREATMENT DURATION; TREATMENT OUTCOME;

ADULT; AGED; CALCIUM; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NAPHTHALENES; PARATHYROID GLANDS; PARATHYROID HORMONE; PHOSPHORUS; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70349336597     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2009.00772.x     Document Type: Article

References (11)

1. Braun J, Oldendorf M, Moshage W et al. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996 27 : 394 401.
2. Goodman WG, Goldin J, Kuizon BD et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000 342 : 1478 1483.
3. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001 38 : 938 942.
4. Raggi P, Boulay A, Chasan-Taber S et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 2002 39 : 695 701.
5. Blacher J, Guerin AP, Pannier B et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999 99 : 2434 2439.
6. Wilson PW, Kauppila LI, O'Donnell CJ et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001 103 : 1529 1534.
7. London GM, Guérin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003 18 : 1731 1740.
8. Fukagawa M, Yumita S, Akizawa T et al. Cinacalcet (KRN 1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorous and calcium level in Japanese patients. Nephrol Dial Transplant 2008 23 : 328 335.
9. Block GA, Martin KJ, de Francisco AL et al. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004 350 : 1516 1525.
10. Meola M, Petrucci I, Barsotti G. Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism. Nephrol Dial Transplant 2009 24 : 982 989.
11. Tanaka M, Nakanishi S, Komaba H et al. Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism. NDT Plus 2008 1 : iii49 53.